スポンサーリンク
Division Of Gastroenterology Department Of Internal Medicine Hyogo College Of Medicine | 論文
- Gastric acid secretion in cholecystokinin-1 receptor, -2 receptor, and -1, -2 receptor gene knockout mice
- Enhanced gastric emptying of a liquid gastric load in mice lacking cholecystokinin-B receptor : a study of CCK-A, B, and AB receptor gene knockout mice
- Mechanism of carcinogenesis in familial tumors
- IL18 polymorphism is associated with an increased risk of Crohn's disease
- Effect of Leukocytapheresis Therapy Using a Leukocyte Removal Filter in Crohn's Disease
- Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease
- Solitary Metastatic Malignant Melanoma of the Small Intestine : Findings Obtained during Intraoperative Enteroscopy
- Ischemic Colitis Associated with Systemic Lupus Erythematosus ; Report of a Case
- Pancreatic pseudocyst associated with eating disorder
- Disruption of Cholecystokinin (CCK)-B Receptor Gene Did Not Modify Bile or Pancreatic Secretion of Pancreatic Growth : A Study in CCK-B Receptor Gene Knockout Mice
- Type 1 Diabetes Mellitus Associated with Clinical Acute Pancreatitis in an Adult
- Development of consensus statements for the diagnosis and management of intestinal Behcet's disease using a modified Delphi approach
- Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients
- Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease : an open multicenter prospective study
- Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy
- Gastroduodenitis associated with ulcerative colitis
- Selective Platelet Removal as a Novel Therapy for Refractory Crohn's Disease
- Sargramostim in patients with Crohn's disease : results of a phase 1-2 study
- Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications
- Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial